Legal & General Group
INFI

Legal & General Group’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Legal & General Group’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-6,988
Closed -$4K – 3509
2022
Q2 		$4K Sell
6,988
-2,050
-23% -$1.57K ﹤0.01% 3467
2022
Q1 		$10K Hold
9,038
– – ﹤0.01% 3412
2021
Q4 		$20K Hold
9,038
– – ﹤0.01% 3281
2021
Q3 		$31K Hold
9,038
– – ﹤0.01% 3123
2021
Q2 		$27K Buy
+9,038
New +$28.6K ﹤0.01% 3183
2017
Q3 		– Sell
-349,346
Closed -$548K – 3331
2017
Q2 		$548K Buy
349,346
+335,538
+2,430% +$647K ﹤0.01% 2033
2017
Q1 		$44K Sell
13,808
-4,726
-25% -$11.6K ﹤0.01% 2895
2016
Q4 		$25K Buy
18,534
+11,255
+155% +$14.7K ﹤0.01% 3082
2016
Q3 		$11K Hold
7,279
– – ﹤0.01% 2848
2016
Q2 		$10K Hold
7,279
– – ﹤0.01% 2884
2016
Q1 		$39K Hold
7,279
– – ﹤0.01% 2515
2015
Q4 		$56K Hold
7,279
– – ﹤0.01% 2404
2015
Q3 		$59K Hold
7,279
– – ﹤0.01% 2362
2015
Q2 		$76K Hold
7,279
– – ﹤0.01% 2319
2015
Q1 		$106K Hold
7,279
– – ﹤0.01% 2000
2014
Q4 		$124K Sell
7,279
-380
-5% -$5.53K ﹤0.01% 1825
2014
Q3 		$105K Buy
+7,659
New +$91.2K ﹤0.01% 1854

Other funds holding INFI

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
MIAN
Mariner Independent Advisor Network Overland Park, Kansas $2.33B AUM 14.85% 1-Year Est. Return
GC
Gratus Capital Atlanta, Georgia $2.5B AUM 32.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
EI
EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Legal & General Group's INFI Position: Q3 2022 in Review

Legal & General Group sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q3 2022, closing a stake of 6,988 shares — an estimated $4K sold.

Legal & General Group first reported a position in INFI in Q3 2014 and held it in 17 quarters. The position peaked at $548K in Q2 2017. 76 funds tracked by Wall St. Rank hold INFI as of Q3 2022.

  • Legal & General Group reported no remaining Infinity Pharmaceuticals, Inc. position as of Q3 2022 after selling out during the quarter.
  • Legal & General Group sold 6,988 Infinity Pharmaceuticals, Inc. shares in Q3 2022, an estimated $4K.
  • Legal & General Group first reported a position in Infinity Pharmaceuticals, Inc. in Q3 2014 and held it in 17 quarters.
  • Legal & General Group's Infinity Pharmaceuticals, Inc. position peaked at $548K in Q2 2017.
  • 76 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q3 2022.

Based on Legal & General Group's 13F filing for Q3 2022, filed 14 Nov 2022.